期刊文献+

新型肿瘤标志物CK18—3A9血清水平对胃癌诊断的价值 被引量:4

The diagnosis value of a new tumor marker CK18-3A9 serum level for gastric cancer
原文传递
导出
摘要 目的观察和探讨新型肿瘤标志物细胞角蛋白18片段(CKl8—3A9)血清水平对胃癌的诊断价值。方法采用化学发光法检测并比较350例胃癌、150例胃炎和500名健康体检者空腹血清中CKl8—3A9水平,对比血清CKl8-3A9与CA72—4水平对胃癌的诊断效果。结果CKl8—3A9诊断胃癌灵敏度为46.29%,特异度为96.92%;CA72—4灵敏度为26.00%,特异度为93.23%。CKl8—3A9灵敏度和特异度明显高于CA72—4(P〈0.001)。结论新型肿瘤标志物CKl8-3A9血清水平检测对胃癌能起到临床辅助诊断的作用。 Objective To investigate the diagnosis value of a new tumor marker CK18-3A9 in gastric cancer patients. Methods The serum level of CK18-3A9 in 350 gastric cancer patients, 150 gastritis patients and 500 healthy controls was detected with chemoluminescence, the diagnosis efficacy between the serum CK18-3A9 and CA72-4 was compared. Results The sensitivity, specificity of CK18-3A9 were 46.29 % and 96.92 %, but the sensitivity, specificity of CA72-4 were 26.00 % and 93.23 %, respectively. The differences were significant (P 〈0.001). Conclusion The serum level of CK18-3A9 maybe a new auxiliary diagnosis marker for gastric cancer.
出处 《肿瘤研究与临床》 CAS 2010年第11期733-735,共3页 Cancer Research and Clinic
关键词 胃肿瘤 角蛋白18 CA72—4 Stomach neoplasms Keratin-18 CA72-4
  • 相关文献

参考文献10

二级参考文献32

共引文献33

同被引文献71

  • 1时广利,时广利,尹颜军,时广利,刘继芬,荣长利,时广利,梁子坤.肺癌患者血清中新型肿瘤标志物CK18-3A9检测的临床意义[J].中华临床医师杂志(电子版),2012,6(19):5831-5833. 被引量:6
  • 2索金友,顾红光,王阁.原发性肝癌中CK7的表达及其意义[J].消化外科,2005,4(2):128-131. 被引量:7
  • 3黄玲莎,劳明,沈菁,陈艳华,赵惠柳.GPDA、CA72-4、CA50联检在胃癌诊断中的价值[J].肿瘤防治研究,2005,32(9):560-561. 被引量:6
  • 4任绍青,牛福河,崔建军,董建洲.CA_(72-4)、CA_(19-9)、CEA联合检测在胃癌诊断中的应用[J].河南外科学杂志,2006,12(6):11-11. 被引量:8
  • 5Mizuguchi S, Nishiyama N, Iwata T, et al. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer. Ann Thorac Surg, 2007, 83:216-221.
  • 6Chandler JS, Calnnek D, Quzroni A. Identification and characterization of rat intestinal keralins. Molecular cloning of cDNAs encoding eytokeratins 8, 19, and a new 49-kDa type I cytokeratin (cytokeratin 21) expressed by differentialed intestinal epithelial cells. J Biol Chem, 1991, 66:11932-11938.
  • 7Bodenmueller H. The biochemistry of CYFRA21-1 and other cytokeratin tests. Scand J Clin Lab Inves, 1995, 55 (suppl 221) : 61.
  • 8Barak V, Goike H, Panaretakis KW, et al. Clinical utility of cytokeratins as tumor markers. Clin Biochem, 2004, 37: 529-540.
  • 9Molina R, Filella X, Auge JM, et al. Tumor markers ( CEA, CA125, CYFRA 21-1, SCC and NSE ) in patients with non small cell lung cancer as an aid in histological diagnosis and prognosis. Tumour Biol, 2003, 24:209-218.
  • 10SpodenGA,Mazurek S,Morandell D,et al. Isotype specific inhibi- tots of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation[J]. Int J Cancer, 2008,123(2):312-321.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部